Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.03B P/E - EPS this Y 13.50% Ern Qtrly Grth -
Income -190.42M Forward P/E -6.43 EPS next Y 15.20% 50D Avg Chg -6.00%
Sales 174.91M PEG -0.62 EPS past 5Y - 200D Avg Chg -15.00%
Dividend N/A Price/Book 2.34 EPS next 5Y 21.00% 52W High Chg -42.00%
Recommedations 2.70 Quick Ratio 3.66 Shares Outstanding 86.48M 52W Low Chg 3.00%
Insider Own 28.48% ROA -26.62% Shares Float 46.43M Beta 0.18
Inst Own 72.03% ROE -50.37% Shares Shorted/Prior 3.92M/5.75M Price 13.12
Gross Margin -38.66% Profit Margin -108.87% Avg. Volume 457,983 Target Price 27.52
Oper. Margin -108.55% Earnings Date Aug 7 Volume 349,404 Change -3.46%
About Deciphera Pharmaceuticals, Inc.

Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. The company is also developing vimseltinib, an orally administered, potent, and highly selective switch-control kinase inhibitor of colony stimulating factor 1 receptor (CSF1R) for the treatment of tenosynovial giant cell tumor (TGCT); and DCC-3116 to treat RAS/RAF mutant cancers that is in the preclinical-stage. Deciphera Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts. As of June 11, 2024, Deciphera Pharmaceuticals, Inc. operates as a subsidiary of Ono Pharmaceutical Co., Ltd.

DCPH Chatroom

User Image Tumble51 Posted - 10/30/24

$QURE ..I said the same thing about $DCPH ..an inexperienced CEO HOERTER who was a manufacturing engineer, NEVER A CEO..and he sold DCPH for 50 CENTS on the dollar or $25 a share …a $50 dollar company , that he , like Matt , fcuked up. Once fcuked up, they end up with siht offers , and cash is low and CEO’s without deep pocket friends , CAVE !!!! matt will cave for 50 cents on the dollar , because he too , is without a brain , BUT BUT a stock broker and they only care about themselves and their commission! Thus Matt will tell the board, lol, it is a good deal , lol..when it is a fire sale and Mat gets to walk on HIS BIG FCUK UP ! 400M and Pennies on royalties, won’t get the HD drug thru the FDA without more dilution or some fcuk up by Matt in a private placement , lol I called DCPH to a tee, back in 2019 , I was right

User Image NVDAMillionaire Posted - 3 months ago

$DCPH Deciphera Pharmaceuticals, Inc. (DCPH): Poised for Continued Growth with Promising Pipeline and Robust Commercial Execution http://beyondspx.com/2024/08/05/deciphera-pharmaceuticals-inc-dcph-poised-for-continued-growth-with-promising-pipeline-and-robust-commercial-execution/

User Image LieutenantJoe Posted - 3 months ago

$DCPH whats going on here???

User Image UltimateTrader_22 Posted - 4 months ago

$CBDW .041 +15.49% HOD .0447 3-Month Performance +56.00% YTD Performance +46.84% www.cbdw.ai $SLNO $DCPH

User Image Tumble51 Posted - 4 months ago

$AGIO Only bright spot here is that Steven Hoerter was overlooked as a CEO ( was employed at AGIOS) and the company took useless Fouse ( schenkien’s buddy from celgene) since that imbecile went to $DCPH .. totally screwed shareholders in 2019 doing offerings at 50, there, for needed cash, for their Gist product ( that Pfizer was eating their lunch with , lol ) ignored those $50 investors for 2 years , stock collapsed to $6 , pay back is sweet ( they dumped his a$$) then needed money again at 10 …and then sold the pos at $25 …were he here, stock would be at $12… Never forget the name Hoerter , he will surface and he is useless.

User Image Tumble51 Posted - 5 months ago

$DCPH It was headed to the gutter due to Steve Hoerter, but got saved at a 50% discount to its worth. Haha..the whole mgmt team deserved that screwing , haha

User Image ThaRockefeller Posted - 5 months ago

$DCPH where is this headed ?

User Image dreamleif Posted - 5 months ago

$DCPH I did nothing with the tender offer and just found this one can't trade anymore. What should I expected to get with my shares? Thanks

User Image Stock_Titan Posted - 5 months ago

$DCPH Ono Announces Results of Tender Offer to Acquire Deciphera Pharmaceuticals and Completion of Acquisition of Deciphera (a Wholly Owned Subsidiary of Ono) https://www.stocktitan.net/news/DCPH/ono-announces-results-of-tender-offer-to-acquire-deciphera-3ma3ba1r0upf.html

User Image tradethehalt Posted - 5 months ago

$DCPH trade halt (T12) was alerted to our Members at 7:50pm EDT. Halt price: $25.61 Vol: 1.59M.

User Image HaltTradeAlert Posted - 5 months ago

$DCPH Halt Time: 19:50:00 Issue Symbol: DCPH Reason Code: T12 Last Price: $25.59 Market Cap: $2212920853 Volume: 1572857.0 Relative Volume: 1.32 Shares Float: 86476000 Our members get this alert real time and sent to their phone just like a text. Members also get free real time news catalyst alerts! Go to our website and join our community for free! www.HaltTradeAlert.com

User Image Bigballzzz Posted - 5 months ago

$DCPH Is anyone not taking the offer and does anyone know what happens if you don’t?

User Image Stock_Titan Posted - 5 months ago

$DCPH Deciphera Pharmaceuticals Announces Oral Presentation of Results from MOTION Pivotal Phase 3 Study of Vimseltinib in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the 2024 ASCO Annual Meeting and Online Publication in The Lancet https://www.stocktitan.net/news/DCPH/deciphera-pharmaceuticals-announces-oral-presentation-of-results-lz2pu02k4dw6.html

User Image daretoinvest Posted - 05/30/24

@abdullahyim $DCPH $HIMS are two examples which I know that shot back up after being trashed mercilessly.

User Image intratio Posted - 6 months ago

https://www.intratio.com/stock-forecast/DCPH Deciphera Pharmaceuticals, Inc. Our artificial intelligence foresees that this stock s value has a rather grim outlook for the immediate future and has a dramatic negative long-term outlook $DCPH

User Image intratio Posted - 6 months ago

https://www.intratio.com/stock-forecast/DCPH Deciphera Pharmaceuticals, Inc. Our mathematical model reaches the conclusion that the price action of this stock will drop in the coming days and foretells a grimly dismal future $DCPH

User Image intratio Posted - 6 months ago

$DCPH https://www.intratio.com/stock-forecast/DCPH Our statistical model has forecasted that this equity s value will instantly and significantly lessen and has non-existing long-term fundamentals

User Image intratio Posted - 6 months ago

https://www.intratio.com/stock-forecast/DCPH Our trained A.I. concludes that the value of this equity will instantly and significantly lessen and will continue to have a very poor trend over the next months $DCPH

User Image ThaRockefeller Posted - 6 months ago

$DCPH this will eventually come down

User Image intratio Posted - 6 months ago

$DCPH https://www.intratio.com/stock-forecast/DCPH The statistical model deduces this company s stock price has a rather grim outlook for the immediate future and projects a dramatically gloomy future

User Image Mergerbrief Posted - 6 months ago

$DCPH Ono Pharmaceutical Co Ltd - HSR File By Date MergerBrief.com

User Image intratio Posted - 6 months ago

https://www.intratio.com/stock-forecast/DCPH Deciphera Pharmaceuticals, Inc. The machine learning model calculated the market value of this company will decrease during the next few days and will continue to have a very poor trend over the next months $DCPH

User Image jeepman Posted - 6 months ago

$DCPH

User Image intratio Posted - 6 months ago

$DCPH https://www.intratio.com/stock-forecast/DCPH The engine is making the inference this stock s price clearly has a bad short-term setup and has a dramatic negative long-term outlook

User Image intratio Posted - 6 months ago

https://www.intratio.com/stock-forecast/DCPH Our predictive algorithm has forecasted the value of this stock will soon start to trend dramatically lower and has a dramatic negative long-term outlook $DCPH

User Image intratio Posted - 6 months ago

$DCPH https://www.intratio.com/stock-forecast/DCPH Deciphera Pharmaceuticals, Inc. Our predictive algorithm reaches the conclusion that this company s stock price will shortly drop with a very negative long-term outlook

User Image intratio Posted - 6 months ago

$DCPH https://www.intratio.com/stock-forecast/DCPH Deciphera Pharmaceuticals, Inc. The predictive algorithm assessed the stock price of this company has a poor outlook for the near future and its stock price is in line with its long-term fundamentals

User Image BondbutnotJames Posted - 6 months ago

(2of2) feet. In a lot of countries it has not been possible to prevent cannabis from remaining outlawed - but the free economy is not allowed to regulate things the way they should be regulated - as I have heard. Markets are created there because the circumstances do not allow them to do without imports. Sooner or later, companies like Aurora $ACB are all going to be bagged by companies. What I'm writing to you is called economic analysis and I know what I'm talking about. A few weeks ago I made a statement on the future development of $DCPH - on Monday $DCPH was acquired. Thinking people...can be very helpful - also about why others want your shares.

User Image DaBullRunner Posted - 6 months ago

You seen my MONSTER alerts like $DCPH👇🏦 🚨Smart money is also loading up on CLRO 🚨 They have NO debt and more cash than their entire Market Cap They have the TOP OF THE FOOD CHAIN companies as customers👇😳

User Image theflynews Posted - 6 months ago

Biotech Alert: Searches spiking for these stocks today - $DCPH - https://thefly.com/permalinks/entry.php/DCPHid3909218

Analyst Ratings
Guggenheim Neutral Apr 30, 24
JMP Securities Market Perform Apr 30, 24
Barclays Equal-Weight Apr 30, 24
JonesTrading Hold Apr 29, 24
Jefferies Hold Apr 29, 24
JP Morgan Neutral Mar 20, 24
Stifel Buy Feb 7, 24
Stifel Buy Oct 31, 23
HC Wainwright & Co. Buy Oct 31, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Brightstar Associates LLC 10% Owner 10% Owner Jan 24 Buy 18.00 1,666,666 29,999,988 19,718,014 01/24/23
Flynn Daniel Lee Chief Scientific Off.. Chief Scientific Officer Jan 17 Sell 21.2413 2,403 51,043 43,695 01/19/23
Pitman Jama See Remarks See Remarks Jan 17 Sell 21.2413 1,603 34,050 35,058 01/19/23
Sherman Matthew L EVP & Chief Medical.. EVP & Chief Medical Officer Jan 17 Sell 21.2413 2,403 51,043 72,628 01/19/23
Martin Daniel C. Chief Commercial Off.. Chief Commercial Officer Jan 17 Sell 21.2413 1,603 34,050 48,389 01/19/23
Kelly Thomas Patrick Chief Financial Offi.. Chief Financial Officer Jan 17 Sell 21.2413 2,403 51,043 43,677 01/19/23
Brightstar Associates LLC 10% Owner 10% Owner Apr 29 Buy 10.00 1,478,978 14,789,780 18,051,348 04/29/22
Flynn Daniel Lee Chief Scientific Off.. Chief Scientific Officer Feb 16 Sell 9.05 1,366 12,362 47,866 02/18/22
Martin Daniel C. Chief Commercial Off.. Chief Commercial Officer Feb 16 Sell 9.05 1,146 10,371 48,668 02/18/22
Sherman Matthew L EVP & Chief Medical.. EVP & Chief Medical Officer Feb 16 Sell 9.05 984 8,905 76,790 02/18/22
Kelly Thomas Patrick Chief Financial Offi.. Chief Financial Officer Feb 16 Sell 9.05 1,368 12,380 47,848 02/18/22
Taylor Michael Douglas Director Director Apr 06 Option 1.89 8,000 15,120 8,000 04/06/21
Taylor Michael Douglas Director Director Apr 06 Sell 45.74 8,000 365,920 04/06/21
Kelly Thomas Patrick Chief Financial Offi.. Chief Financial Officer Sep 10 Option 1.89 9,000 17,010 10,040 09/10/20
Kelly Thomas Patrick Chief Financial Offi.. Chief Financial Officer Sep 10 Sell 46.05 9,000 414,450 7,040 09/10/20